TRANSLATIONAL RENAL RESEARCH

E Thomas, KEK Chai, CMY Lee S Randall, M Epstein, A Irish, G Dwivedi, NSR Lan, JH Boyd, D Hendrie, S Robinson, A Chakera, “Five-Year Outcomes of Chronic Kidney Disease in a Longitudinal Population-Based Cohort in Western Australia,” 2026. Nephrology 31, no. 2: e70172, https://doi.org/10.1111/nep.70172

X Wang, R Hussein, N Grobe, L Watson, N Taylor, LC Wang, K Mulroney, A Chakera, P Kotanko, #1513 Evaluating leukocyte test strips for peritonitis diagnosis in peritoneal dialysis patients, Nephrology Dialysis Transplantation, 2025. Volume 40, Issue Supplement 3, October 2025, gfaf116.0640, https://doi.org/10.1093/ndt/gfaf116.0640

MK Kopczyk,  JP Ramsay, KT Mulroney, E Salisbury, WS Ho, CF Carson, E Colombi, T Paton, A Chakera. 2025. Flying under the radar: vancomycin heteroresistance in Staphylococcus epidermidis peritonitis is associated with treatment failure. ASM Case Rep 1:e00007-25. https://doi.org/10.1128/asmcr.00007-25

A Jacques, E Lloyd, SA Muhktar, P Yeoh, B MCMullen, A Chakera, J Codde. Risk prediction model for early detection of urinary tract infection in a hospital setting in Australia. 2025. Health Information Management Journal. 2025;0(0). https://doi.org/10.1177/18333583251363725

A Chakera, A Stirnweiss, J Stevenson, M Kerfoot, A Martin, S Das, G Syn, A Kundu, S Mudumba, P Cunningham. 2025. A Phase 1A Clinical Trial of PYC-003 for the Treatment of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD). Nephrology 2025 Aug 1 (Vol. 30).

D Geetha, FB Cortazar, A Bruchfeld, A Kronbichler, A Karras, GN Nakhoul, PA Merkel, S Bray, AM Bozeman, DRW Jayne, C Au Peh, A Chakera, et al. 2025, “Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement”, Kidney International Reports, 10, 8 Pages 2751-2765, https://doi.org/10.1016/j.ekir.2025.05.041

S Robinson, D Hendrie, R Varhol, K Mehta, E Thomas, J Boyd, K Chai, A Chakera, C Lee, S Randall. 2025, Understanding Chronic Kidney Disease in Western Australia: Cost, Prevalence and Equity. In 2025 World Congress on Health Economics 2025 Jul 21. IHEA.

WA Davis, A Chakera, SAP Chubb, TME Davis. 2025, Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2, Journal of the Endocrine Society, Volume 9, Issue 6, June 2025, bvaf062, https://doi.org/10.1210/jendso/bvaf062

N Pizzino, M Pugliese, M Soye, A Chakera, APW Kumarasinghe. 2025, Incorporating the Clinical Frailty Scale into routine outpatient nephrology practice: a 3-year follow-up of outcomes and associations. Internal Medicine Journal, 55: 839-845. https://doi.org/10.1111/imj.70009

A Mallawaarachchi, H McCarthy, TA Forbes, K Jayasinghe, C Patel, SI Alexander, R Boughtwood, J Braithwaite, A Chakera, et al. Enhancing diagnostic outcomes in kidney genetic disorders: the KidGen national kidney genomics study protocol. BMC Nephrology 26, 51 (2025). https://doi.org/10.1186/s12882-024-03926-y